MAXLINEAR INC (MXL)

US57776J1007 - Common Stock

20.13  +0.14 (+0.7%)

After market: 20.1 -0.03 (-0.15%)

Fundamental Rating

2

Overall MXL gets a fundamental rating of 2 out of 10. We evaluated MXL against 107 industry peers in the Semiconductors & Semiconductor Equipment industry. MXL may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, MXL is valued expensive at the moment.



2

1. Profitability

1.1 Basic Checks

In the past year MXL was profitable.
In the past year MXL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MXL reported negative net income in multiple years.
Each year in the past 5 years MXL had a positive operating cash flow.

1.2 Ratios

The Return On Assets of MXL (-15.04%) is worse than 78.30% of its industry peers.
Looking at the Return On Equity, with a value of -24.29%, MXL is doing worse than 72.64% of the companies in the same industry.
Industry RankSector Rank
ROA -15.04%
ROE -24.29%
ROIC N/A
ROA(3y)2.61%
ROA(5y)-0.93%
ROE(3y)5.47%
ROE(5y)-2.72%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MXL's Gross Margin of 54.55% is fine compared to the rest of the industry. MXL outperforms 69.81% of its industry peers.
MXL's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for MXL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.75%
GM growth 5Y0.51%

2

2. Health

2.1 Basic Checks

MXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MXL has been increased compared to 1 year ago.
Compared to 5 years ago, MXL has more shares outstanding
Compared to 1 year ago, MXL has a worse debt to assets ratio.

2.2 Solvency

MXL has an Altman-Z score of 2.75. This is not the best score and indicates that MXL is in the grey zone with still only limited risk for bankruptcy at the moment.
MXL has a Altman-Z score of 2.75. This is comparable to the rest of the industry: MXL outperforms 43.40% of its industry peers.
MXL has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MXL (0.19) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 2.75
ROIC/WACCN/A
WACC12.43%

2.3 Liquidity

A Current Ratio of 1.99 indicates that MXL should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.99, MXL is doing worse than 72.64% of the companies in the same industry.
A Quick Ratio of 1.56 indicates that MXL should not have too much problems paying its short term obligations.
MXL has a Quick ratio of 1.56. This is in the lower half of the industry: MXL underperforms 69.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.56

4

3. Growth

3.1 Past

The earnings per share for MXL have decreased strongly by -95.97% in the last year.
MXL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.18% yearly.
The Revenue for MXL has decreased by -51.11% in the past year. This is quite bad
MXL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.48% yearly.
EPS 1Y (TTM)-95.97%
EPS 3Y8.46%
EPS 5Y0.18%
EPS growth Q2Q-128.38%
Revenue 1Y (TTM)-51.11%
Revenue growth 3Y13.15%
Revenue growth 5Y12.48%
Revenue growth Q2Q-61.65%

3.2 Future

Based on estimates for the next years, MXL will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.88% on average per year.
The Revenue is expected to grow by 4.16% on average over the next years.
EPS Next Y-111.83%
EPS Next 2Y-0.41%
EPS Next 3Y15.88%
EPS Next 5YN/A
Revenue Next Year-31.54%
Revenue Next 2Y-1.89%
Revenue Next 3Y4.16%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 125.81, the valuation of MXL can be described as expensive.
61.32% of the companies in the same industry are cheaper than MXL, based on the Price/Earnings ratio.
MXL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.02.
MXL is valuated rather expensively with a Price/Forward Earnings ratio of 18.29.
78.30% of the companies in the same industry are more expensive than MXL, based on the Price/Forward Earnings ratio.
MXL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.58.
Industry RankSector Rank
PE 125.81
Fwd PE 18.29

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as MXL's earnings are expected to grow with 15.88% in the coming years.
PEG (NY)N/A
PEG (5Y)694.48
EPS Next 2Y-0.41%
EPS Next 3Y15.88%

0

5. Dividend

5.1 Amount

No dividends for MXL!.
Industry RankSector Rank
Dividend Yield N/A

MAXLINEAR INC

NASDAQ:MXL (5/6/2024, 7:16:41 PM)

After market: 20.1 -0.03 (-0.15%)

20.13

+0.14 (+0.7%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.67B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 125.81
Fwd PE 18.29
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)694.48
Profitability
Industry RankSector Rank
ROA -15.04%
ROE -24.29%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 54.55%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.99
Quick Ratio 1.56
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-95.97%
EPS 3Y8.46%
EPS 5Y
EPS growth Q2Q
EPS Next Y-111.83%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-51.11%
Revenue growth 3Y13.15%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y